imatinib mesylate has been researched along with Mitral Incompetence in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernard, PL; Cinq-Mars, A; Cloutier, S; Dubois, M; Larose, É; Leblanc, MH; Sénéchal, M | 1 |
| Kio, EA; Lazarchick, J; Onitilo, AA; Singh, AK | 1 |
| Binder, T; Jäger, U; Krauth, MT; Ohler, L; Valent, P | 1 |
3 other study(ies) available for imatinib mesylate and Mitral Incompetence
| Article | Year |
|---|---|
Management of Loeffler's Endocarditis With Bivalvular Involvement and a FIP1L1/PDGFRA-Negative Mutation.
Topics: Adult; Bioprosthesis; Echocardiography; Fibrosis; Genetic Testing; Heart Valve Prosthesis Implantation; Heart Ventricles; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Magnetic Resonance Imaging, Cine; Male; Mitral Valve; Mitral Valve Insufficiency; Papillary Muscles; Protein Kinase Inhibitors; Thrombosis; Treatment Outcome; Tricuspid Valve | 2016 |
Cytogenetic remission with imatinib therapy in hypereosinophilic syndrome with trisomy 8 and resolution of severe cardiac dysfunction.
Topics: Aortic Valve Insufficiency; Benzamides; Cardiomegaly; Chromosomes, Human, Pair 8; Cytogenetic Analysis; Heart Diseases; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Middle Aged; Mitral Valve Insufficiency; Piperazines; Pyrimidines; Remission Induction; Trisomy | 2005 |
Improvement of cardiac function, mitral regurgitation and pulmonary hypertension in a patient with chronic eosinophilic leukemia (CEL) after low dose imatinib therapy.
Topics: Adult; Antineoplastic Agents; Benzamides; Heart Failure; Humans; Hypereosinophilic Syndrome; Hypertension, Pulmonary; Imatinib Mesylate; Male; Mitral Valve Insufficiency; Piperazines; Protein-Tyrosine Kinases; Pyrimidines | 2008 |